Icahn School of Medicine: Potential New Therapies for Alzheimer's Disease are Revealed Through Network Modeling of Its Complex Molecular Interactions
November 25, 2020
November 25, 2020
NEW YORK, Nov. 25 -- The Icahn School of Medicine at Mount Sinai issued the following news release:
Researchers from Mount Sinai and the National Center for Geriatrics and Gerontology in Japan have identified new molecular mechanisms driving late-onset Alzheimer's Disease (LOAD), as well as a promising therapeutic candidate for treatment, according to a study in the journal Neuron. LOAD is the most prevalent form of dementia among people over age 65, a progressive and irreversible b . . .
Researchers from Mount Sinai and the National Center for Geriatrics and Gerontology in Japan have identified new molecular mechanisms driving late-onset Alzheimer's Disease (LOAD), as well as a promising therapeutic candidate for treatment, according to a study in the journal Neuron. LOAD is the most prevalent form of dementia among people over age 65, a progressive and irreversible b . . .